poisar

Stocks · News reference

ImmuCell Q2 EPS $0.20 Up From $0.06 YoY, Sales $7.186M Up From $6.445M YoY

Aug 13, 2026, 8:06 PMBenzinga Newsdesk

ImmuCell (NASDAQ:ICCC) reported quarterly earnings of $0.20 per share. This is a 233.33 percent increase over earnings of $0.06 per share from the same period last year. The company reported $7.186 million in sales

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

ICCC
Source
benzinga
Observed
Aug 13, 2026, 8:06 PM
Checked
Aug 13, 2026, 8:06 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 27, 2026, 2:10 PMNa

    ImmuCell Stock Falls 8.8% Despite Y/Y Earnings & Sales Growth in Q2

    ImmuCell Corporation (ICCC) reported Q2 2026 product sales of $7.19 million, up 11.5% year-over-year, with earnings of 20 cents per share versus 6 cents prior year. However, gross margins contracted significantly to 33.9% from 43.7% due to lower production volumes, material quality issues, and cost reclassifications. The stock declined 8.8% post-earnings. Management highlighted strong domestic sales growth of 27.7% and increased market share for First Defense, but noted international headwinds and manufacturing challenges. The company is investing $8 million in facility expansion expected to triple capacity by end of 2027.

    Read original at zacks-investment-research
    ICCC